Director, FIB-SEM Collaboration Core
Pang's primary research focus is to nucleate transformative technology development and to foster discoveries in life science. At YSM, she aims to expand the application of the proprietary enhanced Focused Ion Beam Scanning Electron Microscopy (eFIB-SEM) technology beyond experimental model systems into translational and clinical research. Prior to joining YSM, Pang was the lead scientist in the FIB-SEM Technologies group at the Janelia Research Campus of Howard Hughes Medical Institute. She proposed and developed the enhanced FIB-SEM pipeline beyond Drosophila connectome research. Together with colleagues, she created the very first open-access 3D atlas at the finest isotropic resolution using the eFIB-SEM platform. Inspired to probe brain functions using semiconductor technologies, Pang applied her semiconductor device integration expertise to brain research. She oversaw all facets of device fabrication for customized extracellular neuroprobes and facilitated a partnership between Janelia and IMEC, a leading semiconductor research institute. Her vision and initiative transformed the Neuroprobe project into a massive multi-institute collaboration. During her tenure in the semiconductor industry, Pang contributed to several major technology breakthroughs, from concept initiation to global implementation. At Intel Research, she led process development for a silicon-based optical modulator, achieving a fiftyfold improvement over previous world records. She also spearheaded the integration of Alternate Phase Shift Mask technology into Intel's high-volume manufacturing. At leading semiconductor equipment companies, Pang launched innovative inspection solutions at KLA that revolutionized defect inspection in the photomask industry and introduced the first computational lithography calibration product at ASML, capturing over 90% market share within two years. At YSM, Pang envisions the FIB-SEM Collaboration Core as a discovery powerhouse — a vibrant ecosystem integrating advanced imaging technologies, diverse applications, and robust data pipelines. She welcomes collaborations and looks forward to advancing life science research alongside her team and collaborators.